releases
Study shows better option for treatment of inoperable anal cancer
Jun. 24, 2020—People with inoperable anal cancer treated with carboplatin-paclitaxel had fewer complications and lived longer than those who received another chemotherapy that has been more often administered.
Glaucoma drug studied to prevent lung Infection in COVID-19 patients
Jun. 24, 2020—Vanderbilt University Medical Center is evaluating razuprotafib, a drug used to treat glaucoma, in a new randomized, investigational trial for the prevention and treatment of acute respiratory distress syndrome (ARDS) in adult patients with moderate to severe COVID-19.
Major U.S. trial closes showing no benefit for hydroxychloroquine in COVID-19
Jun. 21, 2020—The Outcomes Related to COVID-19 Treated with Hydroxychloroquine among In-patients with Symptomatic Disease (ORCHID) trial stopped enrolling new patients based on the fourth scheduled interim analysis showing no evidence of benefit or harm.
Robotic technology speeds arrhythmia gene classification
Jun. 12, 2020—Vanderbilt University Medical Center investigators have used high-throughput robotic technology to rapidly study and classify variations in a gene linked to heart rhythm disorders and cardiac conditions.
C.diff captures blood cell cofactor to build defensive shield
Jun. 10, 2020—Vanderbilt University Medical Center scientists have identified a C. diff protein system that senses and captures heme (part of hemoglobin) to build a protective shield that fends off threats from our immune system and antibiotics.
Vanderbilt, AstraZeneca sign new COVID-19 antibody agreement
Jun. 9, 2020—After evaluating the ability of more than 1,500 monoclonal antibodies to bind and neutralize the COVID-19 virus, SARS-CoV-2, in the laboratory, AstraZeneca signed an exclusive license to six candidate antibodies in Vanderbilt’s portfolio.
Tennessee receives grant from federal government to address opioid crisis
Dec. 20, 2019—The Division of TennCare will partner with VUMC as part of the MOM program focusing on 26 rural and urban counties to improve the outcomes for women with opioid use disorder and their infants.
Art professor receives dual honors for groundbreaking work
Jan. 11, 2019—Cornelius Vanderbilt Professor of Fine Arts Maria Magdalena Campos-Pons is the recipient of a prestigious Anonymous Was a Woman grant.
Vanderbilt Osher winter term: Innovation, ‘Julius Caesar’ and more
Dec. 21, 2018—Innovative thinking in the digital age, women in the civil rights movement and acting for opera are among the winter 2019 classes offered by Vanderbilt’s Osher Institute for Lifelong Learners.
Emeritus Divinity professor who turned faith into community activism dies
Nov. 29, 2018—The Rev. Don Beisswenger, a Divinity School emeritus professor who lived out his faith as a dedicated community activist—serving six months in federal prison for a nonviolent protest—has died.
Political surveillance of civil rights activists topic of Seigenthaler Series
Oct. 12, 2018—Political surveillance of civil rights activists is the focus of a Seigenthaler Series talk with author and journalist Marc Perrusquia at the First Amendment Center Oct. 15.
Six alumni join Vanderbilt Student Media Hall of Fame in 2018
Oct. 10, 2018—Six alumni—Bruce Heyman, John Hindle, Scott Hubbard, Paul Kurtz, Richard McCord and Mary Margaret Oliver—are the newest members of the Vanderbilt Student Media Hall of Fame.